FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rhonda Cooper-DeHoff

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Caitrin W McDonough; Carl J Pepine; Stephen T Turner; Taimour Y Langaee; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Sarah E Burbage; Arlene B Chapman; Rhonda M Cooper-DeHoff; Julio Duarte; Yan Gong; John G Gums; Julie A Johnson
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
McKenzie Calhoun; L Brian Cross; Rhonda M Cooper-DeHoff
Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease.
William R Wikoff; Hongjie Zhu; Amber L Beitelshees; Stephen Boyle; Arlene B Chapman; Erik Churchill; Rhonda M Cooper-DeHoff; Oliver Fiehn; Reginald F Frye; Yan Gong; Julie A Johnson; Rima Kaddurah-Daouk
Pharmacometabolomics reveals racial differences in response to atenolol treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rhonda Cooper-DeHoff (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Caitrin W McDonough; Carl J Pepine; Stephen T Turner; Taimour Y Langaee; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Sarah E Burbage; Arlene B Chapman; Rhonda M Cooper-DeHoff; Julio Duarte; Yan Gong; John G Gums; Julie A Johnson
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
Journal of hypertension 2013;31(4):698-704.
2013: McKenzie Calhoun; L Brian Cross; Rhonda M Cooper-DeHoff
Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease.
Expert review of cardiovascular therapy 2013;11(3):289-91.
2013: William R Wikoff; Hongjie Zhu; Amber L Beitelshees; Stephen Boyle; Arlene B Chapman; Erik Churchill; Rhonda M Cooper-DeHoff; Oliver Fiehn; Reginald F Frye; Yan Gong; Julie A Johnson; Rima Kaddurah-Daouk
Pharmacometabolomics reveals racial differences in response to atenolol treatment.
PloS one 2013;8(3):e57639.
2013: Jason H Karnes; Taimour Y Langaee; Caitrin W McDonough; Carl J Pepine; Miguel Ramos; Octavio E Casanova; James R Catlin; Shin-Wen Chang; Yan Gong; Julie A Johnson; Rhonda M Cooper-DeHoff
Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort.
Journal of translational medicine 2013;11():12.
2013: Abdoreza Davoodi-Semiromi; A Hassanzadeh; Martin Wabitsch; C H Wasserfall; Rhonda M Cooper-DeHoff; Mark Atkinson
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.
Immunogenetics 2013;65(1):83-90.
2012: Yan Gong; John G Gums; Wei Hou; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Taimour Y Langaee; Caitrin W McDonough; Stephen T Turner; Zhiying Wang; Julie A Johnson
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Circulation. Cardiovascular genetics 2012;5(6):686-91.
2012: Alexander G Vandell; Taimour Y Langaee; Stephen B Liggett; Maximilian T Lobmeyer; Carl J Pepine; Stephen T Turner; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Brian E Gawronski; Yan Gong; John G Gums; Julie A Johnson
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Hypertension 2012;60(4):957-64.
2012: Steven M Smith; Stephen T Turner; Julie A Johnson; Kent Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Yan Gong; John G Gums
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
American journal of hypertension 2012;25(3):359-65.
2012: Tobias Gerhard; Julie A Johnson; Carl J Pepine; Jonathan Shuster; Babette A Brumback; Rhonda M Cooper-DeHoff; Joseph Ac Delaney; Almut G Winterstein
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
BMC medical research methodology 2012;12():119.
2012: Abdoreza Davoodi-Semiromi; Martin Wabitsch; Clive H Wasserfall; Chang Qing Xia; Michael J Clare-Salzler; Rhonda M Cooper-DeHoff; Mark Atkinson
The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice.
PloS one 2012;7(5):e36079.
2012: Julio Duarte; Roger B Fillingim; Yan Gong; John G Gums; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Ben Burkley; Arlene B Chapman; Rhonda M Cooper-DeHoff; Bruce C Kone; Taimour Y Langaee; Stephen T Turner; Issam Zineh; Julie A Johnson
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
Journal of translational medicine 2012;10():56.
2012: Stephen T Turner; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; John G Gums; Julie A Johnson; Gary L Schwartz; Kent R Bailey
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
Journal of translational medicine 2012;10():47.
2011: Daniel F Pauly; Barry M Sharaf; Karen M Smith; George Sopko; R David Anderson; Rhonda M Cooper-DeHoff; Eileen Handberg; B Delia Johnson; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
American heart journal 2011;162(4):678-84.
2011: Scott J Denardo; Eileen Handberg; C Noel Bairey-Merz; Rhonda M Cooper-DeHoff; George S Sopko; Xuerong Wen; Carl J Pepine
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
Clinical cardiology 2011;34(8):483-7.
2011: Anthony A Bavry; Rhonda M Cooper-DeHoff; Yan Gong; Eileen Handberg; Asma Khaliq; Carl J Pepine
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
The American journal of medicine 2011;124(7):614-20.
2011: Elvin Tyrone Price; Michael A Pacanowski; Michael A Martin; Rhonda M Cooper-DeHoff; Carl J Pepine; Issam Zineh; Julie A Johnson
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
Pharmacogenetics and genomics 2011;21(6):333-40.
2011: Yan Gong; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Maximilian T Lobmeyer; Taimour Y Langaee; Jun Wu; Sharon Cresci; Michael A Province; John A Spertus; Carl J Pepine; Julie A Johnson
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
Circulation. Cardiovascular genetics 2011;4(2):169-78.
2011: Maximilian T Lobmeyer; Liewei Wang; Issam Zineh; Stephen T Turner; John G Gums; Arlene B Chapman; Rhonda M Cooper-DeHoff; Amber L Beitelshees; Kent R Bailey; Eric Boerwinkle; Carl J Pepine; Julie A Johnson
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Pharmacogenetics and genomics 2011;21(1):42-9.
2011: Rhonda M Cooper-DeHoff; Eric F Egelund; Carl J Pepine
Blood pressure lowering in patients with diabetes--one level might not fit all.
Nature reviews. Cardiology 2011;8(1):42-9.
2010: Yuxin Niu; Yan Gong; Taimour Y Langaee; Heather M Davis; Hazem Elewa; Amber L Beitelshees; James I Moss; Rhonda M Cooper-DeHoff; Carl J Pepine; Julie A Johnson
Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
Circulation. Cardiovascular genetics 2010;3(6):548-55.
2010: Hrishikesh A Navare; Reginald F Frye; Rhonda M Cooper-DeHoff; Jonathan J Shuster; Karen Hall; Siegfried O F Schmidt; Stephen T Turner; Julie A Johnson
Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.
Pharmacotherapy 2010;30(9):872-8.
2010: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
American journal of hypertension 2010;23(9):1014-22.
2010: Scott J Denardo; Franz H Messerli; Efrain Gaxiola; Juan M Aranda; Rhonda M Cooper-DeHoff; Eileen M Handberg; Yan Gong; Annette Champion; Qian Zhou; Carl J Pepine
Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
The American journal of cardiology 2010;106(4):498-503.
2010: Scott J Denardo; Yan Gong; Wilmer W Nichols; Franz H Messerli; Anthony A Bavry; Rhonda M Cooper-DeHoff; Eileen M Handberg; Annette Champion; Carl J Pepine
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
The American journal of medicine 2010;123(8):719-26.
2010: Rhonda M Cooper-DeHoff; Yan Gong; Eileen Handberg; Anthony A Bavry; Scott J Denardo; George L Bakris; Carl J Pepine
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
JAMA : the journal of the American Medical Association 2010;304(1):61-8.
2010: C Noel Bairey Merz; Marian B Olson; Candace McClure; Yu-Ching Yang; James Symons; George Sopko; Sheryl F Kelsey; Eileen Handberg; B Delia Johnson; Rhonda M Cooper-DeHoff; Barry L Sharaf; William J Rogers; Carl J Pepine
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
American heart journal 2010;159(6):987.e1-7.
2010: Julio Duarte; Rhonda M Cooper-DeHoff
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics.
Expert review of cardiovascular therapy 2010;8(6):793-802.
2010: Rhonda M Cooper-DeHoff; Carl J Pepine
The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers.
Evidence-based medicine 2010;15(3):92-3.
2010: Amber L Beitelshees; Julie A Johnson; Megan L Hames; Yan Gong; Rhonda M Cooper-DeHoff; Jun Wu; Sharon Cresci; Cynthia X Ma; Carl J Pepine; Michael A Province; John A Spertus; Howard L McLeod
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner.
PloS one 2010;5(12):e15180.
2010: Anthony A Bavry; R David Anderson; Yan Gong; Scott J Denardo; Rhonda M Cooper-DeHoff; Eileen Handberg; Carl J Pepine
Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
Hypertension 2010;55(1):48-53.
2010: Rhonda M Cooper-DeHoff; Sheron Wen; Amber L Beitelshees; Issam Zineh; John G Gums; Stephen T Turner; Yan Gong; Karen Hall; Vishal Parekh; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
Hypertension 2010;55(1):61-8.
2009: Rhonda M Cooper-DeHoff; Eileen M Handberg; Giuseppe Mancia; Qian Zhou; Annette Champion; Udo F Legler; Carl J Pepine
INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Expert review of cardiovascular therapy 2009;7(11):1329-40.
2009: Yan Gong; Eileen Handberg; Tobias Gerhard; Rhonda M Cooper-DeHoff; L Douglas Ried; Julie A Johnson; Carl J Pepine
Systolic blood pressure and subjective well-being in patients with coronary artery disease.
Clinical cardiology 2009;32(11):627-32.
2009: Julie A Johnson; Yan Gong; kent bailey; Rhonda M Cooper-DeHoff; Arlene B Chapman; S T Turner; G L Schwartz; K Campbell; S Schmidt; Amber L Beitelshees; Eric Boerwinkle; John G Gums
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
Clinical pharmacology and therapeutics 2009;86(5):533-9.
2009: Steven M Smith; Shawn D Anderson; Sheron Wen; Yan Gong; Stephen T Turner; Rhonda M Cooper-DeHoff; Gary L Schwartz; Kent Bailey; Arlene B Chapman; Karen L Hall; Hua Feng; Eric Boerwinkle; Julie A Johnson; John G Gums
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Pharmacotherapy 2009;29(10):1157-65.
2009: Amber L Beitelshees; Hrishikesh Navare; Danxin Wang; Yan Gong; Jennifer Wessel; James I Moss; Taimour Y Langaee; Rhonda M Cooper-DeHoff; Wolfgang Sadee; Carl J Pepine; Nicolas J Schork; Julie A Johnson
CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.
Circulation. Cardiovascular genetics 2009;2(4):362-70.
2009: Michael A Pacanowski; Issam Zineh; Rhonda M Cooper-DeHoff; Carl J Pepine; Julie A Johnson
Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension.
American journal of hypertension 2009;22(7):748-53.
2009: Jason H Karnes; Rhonda M Cooper-DeHoff
Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.
Expert review of cardiovascular therapy 2009;7(6):689-702.
2009: Martha Gulati; Rhonda M Cooper-DeHoff; Candace McClure; B Delia Johnson; Leslee J Shaw; Eileen M Handberg; Issam Zineh; Sheryl F Kelsey; Morton F Arnsdorf; Henry R Black; Carl J Pepine; C Noel Bairey Merz
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
Archives of internal medicine 2009;169(9):843-50.
2009: Scott J Denardo; Franz H Messerli; Efrain Gaxiola; Juan M Aranda; Rhonda M Cooper-DeHoff; Eileen Handberg; Yan Gong; Annette Champion; Qian Zhou; Carl J Pepine
Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
Hypertension 2009;53(4):624-30.
2009: Julie A Johnson; Eric Boerwinkle; Issam Zineh; Arlene B Chapman; Kent Bailey; Rhonda M Cooper-DeHoff; John G Gums; R Whit Curry; Yan Gong; Amber L Beitelshees; Gary Schwartz; Stephen T Turner
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
American heart journal 2009;157(3):442-9.
2008: Rhonda M Cooper-DeHoff
Thiazide-induced dysglycemia: it's time to take notice.
Expert review of cardiovascular therapy 2008;6(10):1291-4.
2008: Tobias Gerhard; Yan Gong; Amber L Beitelshees; Xianyun Mao; Maximilian T Lobmeyer; Rhonda M Cooper-DeHoff; Taimour Y Langaee; Nicholas J Schork; Mark D Shriver; Carl J Pepine; Julie A Johnson
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
American heart journal 2008;156(2):397-404.
2008: Rainer Kolloch; Udo F Legler; Annette Champion; Rhonda M Cooper-DeHoff; Eileen Handberg; Qian Zhou; Carl J Pepine
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).
European heart journal 2008;29(10):1327-34.
2008: Leslee J Shaw; C Noel Bairey-Merz; Ricardo Azziz; Frank Z Stanczyk; George Sopko; Glenn D Braunstein; Sheryl F Kelsey; Kevin Kip; Rhonda M Cooper-DeHoff; B Delia Johnson; Viola Vaccarino; Steven E Reis; Vera Bittner; T Keta Hodgson; William Rogers; Carl J Pepine
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
The Journal of clinical endocrinology and metabolism 2008;93(4):1276-84.
2008: Antonio Coca; Franz H Messerli; ATHANASE BENETOS; Qian Zhou; Annette Champion; Rhonda M Cooper-DeHoff; Carl J Pepine
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Stroke; a journal of cerebral circulation 2008;39(2):343-8.
2008: Michael A Pacanowski; Issam Zineh; Haihong Li; B Delia Johnson; Rhonda M Cooper-DeHoff; Vera Bittner; Dennis M McNamara; Barry L Sharaf; C Noel Bairey Merz; Carl J Pepine; Julie A Johnson
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Journal of translational medicine 2008;6():11.
2007: Rhonda M Cooper-DeHoff; Carl J Pepine
Metabolic syndrome and cardiovascular disease: challenges and opportunities.
Clinical cardiology 2007;30(12):593-7.
2007: Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-DeHoff; Qian Zhou; Carl J Pepine
Obesity paradox in patients with hypertension and coronary artery disease.
The American journal of medicine 2007;120(10):863-70.
2007: Amber L Beitelshees; Yan Gong; Danxin Wang; Nicholas J Schork; Rhonda M Cooper-DeHoff; Taimour Y Langaee; Mark D Shriver; Wolfgang Sadee; Harry Knot; Carl J Pepine; Julie A Johnson
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
Pharmacogenetics and genomics 2007;17(9):719-29.
2007: Rhonda M Cooper-DeHoff; Qian Zhou; Efrain Gaxiola; Jose L Cangiano; David Garcia-Barreto; Eileen Handberg; Carl J Pepine
Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST.
Journal of women's health (2002) 2007;16(5):632-40.
2007: Martin Brunner; Rhonda M Cooper-DeHoff; Yan Gong; Jason H Karnes; Taimour Y Langaee; Carl J Pepine; Julie A Johnson
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
The American journal of cardiology 2007;99(11):1549-54.
2007: Taimour Y Langaee; Yan Gong; Hossein Najaf Yarandi; D A Katz; Rhonda M Cooper-DeHoff; Carl J Pepine; Julie A Johnson
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.
Clinical pharmacology and therapeutics 2007;81(3):386-91.
2007: Benjamin J Epstein; Rhonda M Cooper-DeHoff
Effect of ramipril on the incidence of diabetes.
The New England journal of medicine 2007;356(5):523; author reply 523-4.
2007: George L Bakris; Rhonda M Cooper-DeHoff; Qian Zhou; Stuart Kupfer; Annette Champion; Carl J Pepine
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7 Suppl 1():25-9.
2006: Rhonda M Cooper-DeHoff; Jerome D Cohen; George L Bakris; Franz H Messerli; Serap Erdine; Ann C Hewkin; Stuart Kupfer; Carl J Pepine
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
The American journal of cardiology 2006;98(7):890-4.
2006: Rhonda M Cooper-DeHoff; Juan M Aranda; Efrain Gaxiola; Jose L Cangiano; David Garcia-Barreto; C Richard Conti; Ann C Hewkin; Carl J Pepine
Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
American heart journal 2006;151(5):1072-9.
2006: Carl J Pepine; Peter R Kowey; Stuart Kupfer; Rainer E Kolloch; ATHANASE BENETOS; Giuseppe Mancia; Antonio Coca; Rhonda M Cooper-DeHoff; Eileen Handberg; Efrain Gaxiola; Peter Sleight; C Richard Conti; Ann C Hewkin; Luigi Tavazzi
Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Journal of the American College of Cardiology 2006;47(3):547-51.
2006: Rhonda M Cooper-DeHoff; Carl J Pepine
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
European heart journal 2006;27(1):5-6.
2005: William J Elliott; Ann C Hewkin; Stuart Kupfer; Rhonda M Cooper-DeHoff; Carl J Pepine
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(11):654-63.
2005: Issam Zineh; Rhonda M Cooper-DeHoff; Timothy R Wessel; Christopher B Arant; Peter Sleight; Edward A Geiser; Carl J Pepine
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Clinical cardiology 2005;28(7):321-8.
2004: George L Bakris; Efrain Gaxiola; Franz H Messerli; Giuseppe Mancia; Serap Erdine; Rhonda M Cooper-DeHoff; Carl J Pepine
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
Hypertension 2004;44(5):637-42.
2004: Rhonda M Cooper-DeHoff; Eileen Handberg; Jerome Cohen; Peter R Kowey; Franz H Messerli; Giuseppe Mancia; Jose L Cangiano; Efrain Gaxiola; David Garcia-Barreto; Ann C Hewkin; Carl J Pepine
Characteristics of contemporary patients with hypertension and coronary artery disease.
Clinical cardiology 2004;27(10):571-6.
2004: Carl J Pepine; Rhonda M Cooper-DeHoff
Cardiovascular therapies and risk for development of diabetes.
Journal of the American College of Cardiology 2004;44(3):509-12.
2003: Carl J Pepine; Eileen Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter R Kowey; Franz H Messerli; Giuseppe Mancia; Jose L Cangiano; David Garcia-Barreto; Mátyás Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(21):2805-16.
2003: Carl J Pepine; Rhonda M Cooper-DeHoff; Robert J Weiss; Michael Koren; Neville Bittar; Udho Thadani; Margaret C Minkwitz; Eric L Michelson; Howard G Hutchinson
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
The American journal of cardiology 2003;91(3):274-9.
2001: C Richard Conti; Rhonda M Cooper-DeHoff
How will INVEST and other hypertension trials change clinical practice?
Clinical cardiology 2001;24(11 Suppl):V24-9.
2001: Rhonda M Cooper-DeHoff; Eileen Handberg; C Heissenberg; K Johnson
Electronic prescribing via the internet for a coronary artery disease and hypertension megatrial.
Clinical cardiology 2001;24(11 Suppl):V14-6.
2000: Maria B Grant; Robert N Mames; C Fitzgerald; KM Hazariwala; Rhonda M Cooper-DeHoff; Sergio Caballero; K S Estes
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.
Diabetes care 2000;23(4):504-9.
1998: Carl J Pepine; EM Handberg-Thurmond; Ronald G Marks; Michael Conlon; Rhonda M Cooper-DeHoff; Peter Volkers; P Zellig
Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Journal of the American College of Cardiology 1998;32(5):1228-37.